Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Apyx Medical Corp (APYX)

Apyx Medical Corp (APYX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 137,671
  • Shares Outstanding, K 38,242
  • Annual Sales, $ 48,100 K
  • Annual Income, $ -23,460 K
  • EBIT $ -10 M
  • EBITDA $ -9 M
  • 60-Month Beta 1.49
  • Price/Sales 2.87
  • Price/Cash Flow N/A
  • Price/Book 21.71

Options Overview Details

View History
  • Implied Volatility 124.14% (-45.09%)
  • Historical Volatility 49.83%
  • IV Percentile 31%
  • IV Rank 5.97%
  • IV High 691.79% on 09/03/25
  • IV Low 88.10% on 08/13/25
  • Expected Move (DTE 23) 0.00 (0.00%)
  • Put/Call Vol Ratio 20.00
  • Today's Volume 21
  • Volume Avg (30-Day) 10
  • Put/Call OI Ratio 0.25
  • Today's Open Interest 4,060
  • Open Int (30-Day) 4,154
  • Expected Range 3.60 to 3.60

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.06
  • Number of Estimates 1
  • High Estimate -0.06
  • Low Estimate -0.06
  • Prior Year -0.12
  • Growth Rate Est. (year over year) +50.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.46 +4.05%
on 12/19/25
4.25 -15.29%
on 12/03/25
-0.40 (-10.00%)
since 11/21/25
3-Month
1.70 +111.75%
on 09/24/25
4.44 -18.92%
on 11/12/25
+1.51 (+72.25%)
since 09/23/25
52-Week
0.76 +376.57%
on 04/04/25
4.44 -18.92%
on 11/12/25
+1.94 (+116.87%)
since 12/23/24

Most Recent Stories

More News
Apyx Medical Corporation Announces Approval and Commercial Launch of Apyx One Console and Single-Use Handpieces for Cosmetic Surgical Procedures in South Korea

CLEARWATER, Fla., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (Nasdaq: APYX) (the “Company” or “Apyx Medical”) the leader in surgical aesthetics marketed and sold as Renuvion...

APYX : 3.60 (-0.28%)
Apyx Medical Corporation Announces Pricing of $10 Million Public Offering of Common Stock

CLEARWATER, Fla., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (Nasdaq: APYX) (the “Company” or “Apyx Medical”) the leader in surgical aesthetics marketed and sold as Renuvion®...

APYX : 3.60 (-0.28%)
Apyx Medical Corporation Announces Proposed Public Offering of Common Stock

CLEARWATER Fla., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (Nasdaq: APYX) (the “Company” or “Apyx Medical”) the leader in surgical aesthetics marketed and sold as Renuvion®...

APYX : 3.60 (-0.28%)
Apyx: Q3 Earnings Snapshot

Apyx: Q3 Earnings Snapshot

APYX : 3.60 (-0.28%)
Apyx Medical Corporation Reports Third Quarter 2025 Financial Results

Initiated full U.S. commercial launch of AYON Body Contouring System ™ (AYON) at end of Q3 2025, with demand for pre-orders exceeding expectations Submitted new 510(k) for AYON for device label...

APYX : 3.60 (-0.28%)
Apyx Medical Corporation to Participate in Upcoming November Investor Conferences

CLEARWATER, Fla., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency...

APYX : 3.60 (-0.28%)
Apyx Medical Corporation to Release Third Quarter of Fiscal Year 2025 Financial Results on November 6, 2025

CLEARWATER, Fla., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ: APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency...

APYX : 3.60 (-0.28%)
Craig-Hallum Keeps Their Buy Rating on Apyx Medical (APYX)

In a report released today, Matt Hewitt from Craig-Hallum reiterated a Buy rating on Apyx Medical. The company’s shares closed yesterday at $3.40.Elevate Your Investing Strategy: Take advantage of TipRanks...

APYX : 3.60 (-0.28%)
Citizens JMP Sticks to Their Hold Rating for Apyx Medical (APYX)

Citizens JMP analyst David Turkaly reiterated a Hold rating on Apyx Medical today. The company’s shares closed yesterday at $3.40.Elevate Your Investing Strategy: Take advantage of TipRanks Premium at...

APYX : 3.60 (-0.28%)
Apyx Medical Corporation Submits FDA 510(k) for Device Label Expansion of AYON Body Contouring System™ for Power Liposuction

Initiated Nationwide Commercial Launch of AYON in September The Company is Hosting a Virtual Key Opinion Leader Event to Discuss the Commercial Launch of AYON on October 14, 2025 CLEARWATER, Fla.,...

APYX : 3.60 (-0.28%)

Business Summary

Apyx Medical Corporation is an energy technology company. It provides products in the cosmetic and surgical markets. The company's Helium Plasma Technology is marketed and sold as Renuvion(R) in the cosmetic surgery market and J-Plasma(R) in the hospital surgical market. Apyx Medical Corporation, formerly...

See More

Key Turning Points

3rd Resistance Point 3.78
2nd Resistance Point 3.71
1st Resistance Point 3.66
Last Price 3.60
1st Support Level 3.54
2nd Support Level 3.47
3rd Support Level 3.42

See More

52-Week High 4.44
Last Price 3.60
Fibonacci 61.8% 3.03
Fibonacci 50% 2.60
Fibonacci 38.2% 2.16
52-Week Low 0.76

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar